Corpus luteum development: Lessons from genetic models in mice

被引:55
作者
Bachelot, A [1 ]
Binart, N [1 ]
机构
[1] INSERM, U 584 Hormone Targets, Fac Med Rene Descartes, F-75730 Paris, France
来源
CURRENT TOPICS IN DEVELOPMENTAL BIOLOGY, VOLUME 68 | 2005年 / 68卷
关键词
D O I
10.1016/S0070-2153(05)68003-9
中图分类号
Q [生物科学];
学科分类号
07 [理学]; 0710 [生物学]; 09 [农学];
摘要
The corpus luteum is a transient endocrine gland that produces essentially progesterone, a required product for the establishment and maintenance of early pregnancy. In the absence of pregnancy, the corpus luteum will cease to produce progesterone, and the structure itself will regress in size over time. The life span and function of the corpus luteum is regulated by complex interactions between stimulatory (luteotrophic) and inhibitory (luteolytic) mediators. Although the process of luteal formation and regression has been studied for several decades, many of the regulatory mechanisms involved in loss of function and involution of the structure are incompletely understood. In rodents, prolactin is the major luteotrophic hormone by maintaining the structural and functional integrity of the corpus luteum for several days after mating. Other factors involved in steroidogenesis, control of cell cycle, apoptosis, and tissue remodeling have been shown to play a role in corpus luteum development and maintenance. Especially, PGF2 alpha seems to be the most potent luteolytic hormone. One of the most important advances in the study of mammalian genes has been the development of techniques to obtain defined mutations in mice. These tools enable us to target specific genes and to analyze the impact of their loss on cell fate and function. With these approaches, several receptors, transcription factors, enzymes, and other factors have been linked to corpus luteum development and maintenance. These models are helping to define mechanisms of reproductive function and to identify potential new contraceptive targets and genes involved in the pathophysiology of reproductive disorders. (c) 2005, Elsevier Inc.
引用
收藏
页码:49 / +
页数:37
相关论文
共 115 条
[1]
Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways [J].
Acosta, JJ ;
Muñoz, RM ;
González, L ;
Subtil-Rodríguez, A ;
Domínguez-Cáceres, MA ;
García-Martínez, JM ;
Calcabrini, A ;
Lazaro-Trueba, I ;
Martín-Pérez, J .
MOLECULAR ENDOCRINOLOGY, 2003, 17 (11) :2268-2282
[2]
IDENTIFICATION OF A MAJOR PROLACTIN-REGULATED PROTEIN AS 20-ALPHA-HYDROXYSTEROID DEHYDROGENASE - COORDINATE REGULATION OF ITS ACTIVITY, PROTEIN-CONTENT, AND MESSENGER-RIBONUCLEIC-ACID EXPRESSION [J].
ALBARRACIN, CT ;
PARMER, TG ;
DUAN, WR ;
NELSON, SE ;
GIBORI, G .
ENDOCRINOLOGY, 1994, 134 (06) :2453-2460
[3]
PTP1D is a positive regulator of the prolactin signal leading to beta-casein promoter activation [J].
Ali, S ;
Chen, ZJ ;
Lebrun, JJ ;
Vogel, W ;
Kharitonenkov, A ;
Kelly, PA ;
Ullrich, A .
EMBO JOURNAL, 1996, 15 (01) :135-142
[4]
Phosphorylation of steroidogenic acute regulatory protein (StAR) modulates its steroidogenic activity [J].
Arakane, F ;
King, SR ;
Du, Y ;
Kallen, CB ;
Walsh, LP ;
Watari, H ;
Stocco, DM ;
Strauss, JF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (51) :32656-32662
[5]
The lutropin/choriocrctnadotropin receptor, a 2002 perspective [J].
Ascoli, M ;
Fanelli, F ;
Segaloff, DL .
ENDOCRINE REVIEWS, 2002, 23 (02) :141-174
[6]
Cholesterol uptake in adrenal and gonadal tissues: The SR-BI and 'selective' pathway connection [J].
Azhar, S ;
Leers-Sucheta, S ;
Reaven, E .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2003, 8 :S998-S1029
[7]
Berlanga JJ, 1997, J BIOL CHEM, V272, P2050
[8]
Rescue of preimplantatory egg development and embryo implantation in prolactin receptor-deficient mice after progesterone administration [J].
Binart, N ;
Helloco, C ;
Ormandy, CJ ;
Barra, J ;
Clément-Lacroix, P ;
Baran, N ;
Kelly, PA .
ENDOCRINOLOGY, 2000, 141 (07) :2691-2697
[9]
A short form of the prolactin (PRL) receptor is able to rescue mammopoiesis in heterozygous PRL receptor mice [J].
Binart, N ;
Imbert-Bolloré, P ;
Baran, N ;
Viglietta, C ;
Kelly, PA .
MOLECULAR ENDOCRINOLOGY, 2003, 17 (06) :1066-1074
[10]
PROTEOLYTIC REMODELING OF EXTRACELLULAR-MATRIX [J].
BIRKEDALHANSEN, H .
CURRENT OPINION IN CELL BIOLOGY, 1995, 7 (05) :728-735